Ozurdex offers better anatomic outcomes, similar visual acuity vs. anti-VEGF

LONDON — For the treatment of patients with persistent diabetic macular edema, Ozurdex demonstrated better anatomic outcomes, but similar visual acuity results when compared with intravitreal Avastin, according to a speaker here.“However, more eyes in the dexamethasone implant group lost vision,” Mark Gillies, MD, PhD, said at the Euretina Congress.

Full Story →